‌

US Patent 9452213 Genetically detoxified pertussis vaccine that maintains intrinsic adjuvant activity

Patent 9452213 was granted and assigned to Inventprise Llc on September, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Inventprise Llc

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

94522130

Patent Inventor Names

Subhash V. Kapre0

Date of Patent

September 27, 2016

Patent Application Number

148001260

Date Filed

July 15, 2015

Patent Primary Examiner

‌

Padma V Baskar

Patent abstract

The invention is directed to a method for the production of a pertussis vaccine and, in particular, a detoxified pertussis vaccine comprising detoxified pertussis toxin (PT), detoxified pertussis lipopolysaccharide (P-LPS), and detoxified pertussis adenylate cyclase toxin (P-ACT). The invention is also directed to the manufacture of a vaccine or the invention and methods for the administration of a detoxified vaccine to patients.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9452213 Genetically detoxified pertussis vaccine that maintains intrinsic adjuvant activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API